Medicines planning
49 results
Applied filters
The licence and supporting evidence for aflibercept biosimilars
4 February 2026Aflibercept 2mg biosimilars are available for NHS use. Learn about supporting evidence and differences.
National Homecare Medicines Committee (NHMC) Standard Service Areas
12 April 2019In March 2018 NHMC approved a list of standard service areas which will be incorporated into version 6 of the national KPI dataset. Homecare providers…
Lists of new product launches
24 March 2025Annual lists of new products and formulations that have launched, and had licence changes approved. Usually published each February.
New Product Evaluations
22 December 2025A list of new product evaluations that are freely available to NHS staff.
Annual medicines planning publication, Prescribing Outlook
12 January 2026Our annual output to support managed entry and budget planning for new medicines, new indications and patent expiries in the NHS.
Using our annual medicines planning publication, Prescribing Outlook
28 October 2024Users should be aware of the constraints and assumptions in creating Prescribing Outlook, as well as their responsibilities for use.
Annual medicines planning
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.
Preparing to use tocilizumab biosimilar
1 August 2025Introducing biosimilar tocilizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
The licence and supporting evidence for tocilizumab biosimilar
1 September 2025One licensed tocilizumab biosimilar is available: Tyenne. Learn about the licensed indications, supporting evidence and key differences.
Preparing to use omalizumab biosimilar
20 January 2026One omalizumab biosimilar (Omlyclo) is available and other biosimilars are in development. We offer general information and implementation advice.